Oligonucleotide Synthesis Market: Global Market Growth, Trends, and Forecast
The Oligonucleotide Synthesis Market is witnessing strong growth as demand for synthetic DNA and RNA continues to expand across pharmaceutical research, biotechnology, diagnostics, genomics, and therapeutic development.
According to Market Research Future, the global market was valued at USD 4.10 billion in 2025 and is projected to reach USD 12.68 billion by 2035, registering a CAGR of 11.32% during the 2026–2035 forecast period.
The increasing development of nucleic acid therapeutics, including antisense oligonucleotides and RNA-based treatments, is one of the major factors supporting market expansion. The growing use of oligonucleotides in molecular diagnostics, gene synthesis, CRISPR applications, and research is also contributing to demand.
Technological advancements are further transforming the industry. Enzymatic synthesis platforms are emerging as an alternative to conventional phosphoramidite chemistry, while automated and cloud-connected synthesis technologies are improving production efficiency.
North America currently holds the largest market share, supported by strong pharmaceutical and biotechnology research activity. Asia-Pacific is expected to experience particularly rapid growth as countries such as China and India expand their biotechnology and nucleic-acid manufacturing capabilities.
Overall, increasing research investments, therapeutic applications, and technological innovation are expected to drive continued expansion of the global oligonucleotide synthesis industry.